Sattva Sukun submits audited FY26 results to BSE

1 min read     Updated on 08 Jun 2026, 02:25 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Sattva Sukun Lifecare Limited submitted newspaper clippings of its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, to BSE. The company reported a net profit of ₹16.52 lakh for FY26, reversing from a loss in the prior quarter. Total income for the year decreased to ₹423.70 lakh, while expenses rose to ₹420.78 lakh.

powered bylight_fuzz_icon
41246350

*this image is generated using AI for illustrative purposes only.

Sattva Sukun Lifecare Limited submitted newspaper clippings of its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, to BSE Limited. The results were published in Mumbai Lakshadweep (Marathi) and Active Times (English) in compliance with Regulation 47(l)(a) of the SEBI (LODR) Regulations, 2015. The company reported a net profit of ₹16.52 lakh for FY26, reversing from a loss of ₹56.97 lakh in the quarter ended March 31, 2026.

The Board approved the financial results at a meeting held on June 4, 2026, which was rescheduled from May 30, 2026, to complete the audit process. M/s. SSRV & Associates, the statutory auditors, issued an unmodified opinion on the financial statements. Total income from operations for the year stood at ₹423.70 lakh, a decrease from ₹566.69 lakh in the previous year. For the quarter, total income was ₹33.41 lakh compared to ₹131.51 lakh in the corresponding period of the previous year.

Financial Performance

The company reported a profit before tax of ₹2.92 lakh for FY26, significantly lower than ₹318.78 lakh in FY25. Total expenses for the year increased to ₹420.78 lakh from ₹247.91 lakh in the previous year. The basic earnings per share (EPS) for FY26 was ₹0.00, compared to ₹0.13 in the previous year.

Metric Q4FY26 (₹ in Lacs) Q4FY25 (₹ in Lacs) FY26 (₹ in Lacs) FY25 (₹ in Lacs)
Total Income 33.41 131.51 423.70 566.69
Total Expenses 109.32 40.63 420.78 247.91
Net Profit/Loss (56.97) 84.22 16.52 249.02
Basic EPS (0.01) 0.04 0.00 0.13

Rights Issue Utilization

During the financial year 2025-26, the company allotted 19,16,01,248 equity shares on a rights issue basis, raising ₹19.16 crore. The funds were utilized for working capital, business expansion, and investment in subsidiaries. The company confirmed there was no deviation in the use of funds raised.

Trading Window Closure

The trading window for designated persons and their immediate relatives remains closed. The window closed on April 01, 2026, and will reopen 48 hours after the conclusion of the Board Meeting, in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015.

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE280E01038/403ed9a6-2f51-487d-840a-2be9d23fcd23.pdf

Historical Stock Returns for Sattva Sukun Lifecare

1 Day5 Days1 Month6 Months1 Year5 Years
+1.33%+1.33%0.0%+31.03%-19.15%-70.54%

What specific strategies will the company implement to reverse the decline in total income from operations?

How will the ₹19.16 crore raised from the rights issue specifically drive business expansion and improve future profitability?

What measures are being taken to control the significant surge in total expenses observed during FY26?

like16
dislike

Sattva Sukun Lifecare Limited Appoints Two New Directors to Board

2 min read     Updated on 24 Apr 2026, 04:15 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Sattva Sukun Lifecare Limited appointed Mr. Sachin Bhanubhai Manseta as Additional cum Non-Executive Independent Director and Mr. Chirag Dedhia as Additional cum Non-Executive Non-Independent Director effective April 24th, 2026. The appointments were approved during a board meeting held at the company's Mumbai office and comply with SEBI regulations, subject to member approval.

powered bylight_fuzz_icon
38573141

*this image is generated using AI for illustrative purposes only.

Sattva Sukun Lifecare Limited (formerly Mayukh Dealtrade Limited) has announced significant board changes with the appointment of two new directors effective April 24th, 2026. The appointments were approved during a board meeting held at the company's registered office at Office No. 101 on 1st Floor, Crystal Rose C.H.S Datta Mandir Road, Mahavir Nagar, Kandivali West Mumbai.

Board Meeting Details

The board meeting commenced at 12:25 P.M. and concluded at 12:50 P.M. on Friday, April 24th, 2026. The company has informed BSE Limited about these appointments in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

New Director Appointments

The board approved two key appointments during the meeting:

Position Name DIN Role
Additional cum Non-Executive Independent Director Mr. Sachin Bhanubhai Manseta 03471126 Independent Director
Additional cum Non-Executive Non-Independent Director Mr. Chirag Dedhia 08583331 Non-Independent Director

Profile of Mr. Sachin Bhanubhai Manseta

Mr. Sachin Manseta brings extensive experience in secretarial and legal matters to the board. He is described as a dedicated professional with a passion for providing comprehensive solutions in these fields. With years of experience, he has established himself as a trusted advisor and consultant, committed to supporting businesses through every phase of their operations.

Key Details:

  • Not related to any Key Managerial Personnel, Directors, or Promoters of the company
  • Holds directorships in 14 other entities including Anand Property Finance Ltd and various private limited companies
  • Not debarred from holding director positions by SEBI or any other authority

Profile of Mr. Chirag Dedhia

Mr. Chirag Dedhia is a finance professional with strong academic credentials and practical business understanding. He holds a Master's degree in Finance from the University of Surrey, providing him with advanced knowledge in financial analysis, investment strategies, and global markets. He completed his Bachelor of Commerce (B.Com) from Mithibai College, Mumbai.

Professional Background:

  • Expertise in investment analysis and corporate finance
  • Results-oriented mindset focused on financial insight and strategic planning
  • Currently holds directorships in Truestar Enterprise Private Limited, Yummz Snacks and Drinks LLP, and Nyvaan Advisory LLP
  • Not related to any Key Managerial Personnel, Directors, or Promoters of the company

Regulatory Compliance

Both appointments comply with SEBI regulations and circular requirements. The company has confirmed that neither appointee is debarred from holding director positions by SEBI or any other regulatory authority. The appointments are effective from April 24th, 2026, subject to approval by the members of the company.

The notification was signed by Company Secretary Poonam Rani and submitted to BSE Limited for record purposes.

Historical Stock Returns for Sattva Sukun Lifecare

1 Day5 Days1 Month6 Months1 Year5 Years
+1.33%+1.33%0.0%+31.03%-19.15%-70.54%

What strategic initiatives might Sattva Sukun Lifecare pursue with enhanced board expertise in finance and legal matters?

How could the addition of an independent director impact the company's corporate governance practices and investor confidence?

Will these board appointments signal potential expansion plans or new business ventures in the healthcare sector?

like18
dislike

More News on Sattva Sukun Lifecare

1 Year Returns:-19.15%